# EDGAR Filing Document

**Accession Number:** 0002038564
**File Stem:** 0002038564-26-000006
**Filing Date:** 2026-4
**Character Count:** 61854
**Document Hash:** 168792eab28cec17c001759f97621274
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002038564-26-000006.hdr.sgml**: 20260414

**ACCESSION NUMBER**: 0002038564-26-000006

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 41

**CONFORMED PERIOD OF REPORT**: 20260228

**FILED AS OF DATE**: 20260414

**DATE AS OF CHANGE**: 20260413

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Alphega Innovations Corp
- **CENTRAL INDEX KEY:** 0002038564
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 365113418
- **STATE OF INCORPORATION:** WY
- **FISCAL YEAR END:** 1130

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-286526
- **FILM NUMBER:** 26858757

**BUSINESS ADDRESS:**
- **STREET 1:** 30 N. GOULD ST. STE R
- **CITY:** SHERIDAN
- **STATE:** WY
- **ZIP:** 82801
- **BUSINESS PHONE:** (212) 858-7500

**MAIL ADDRESS:**
- **STREET 1:** 30 N. GOULD ST. STE R
- **CITY:** SHERIDAN
- **STATE:** WY
- **ZIP:** 82801

?xml version='1.0' encoding='ASCII'? Alphega Innovations Corp - Form 10-Q SEC filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

**FORM 10-Q**

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended **February 28, 2026**

OR

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to ________

Commission file number: **333-286526**

**Alphega Innovations Corporation**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Wyoming** | **36-5113418** |
| (State or other jurisdiction of<br> incorporation or organization) | (I.R.S. Employer<br> Identification No.) |

---

**30 N Gould St., Ste R**

**Sheridan, WY 82801**

(Address of principal executive offices, including zip code)

**+1 (646) 624-3352**

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: **Not applicable**

Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer", "accelerated filer", "non-accelerated filer", "emerging growth company" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one).

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

i

------

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes ☒ No ☐

As of March 30, 2026, the registrant had 14,930,740 shares of common stock, $0.0001 par value per share, outstanding.

------

ii

------

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
| [PART I - FINANCIAL INFORMATION](#a3) | 1 |
| &nbsp;&nbsp;&nbsp;[Item 1. Financial statements.](#a4) | 1 |
| &nbsp;&nbsp;&nbsp;[Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.](#a5) | 11 |
| &nbsp;&nbsp;&nbsp;[Item 3. Quantitative and Qualitative Disclosures about Market Risk.](#a6) | 14 |
| &nbsp;&nbsp;&nbsp;[Item 4. Controls and Procedures.](#a7) | 15 |
| [PART II - OTHER INFORMATION](#a8) | 16 |
| &nbsp;&nbsp;&nbsp;[Item 1. Legal Proceedings.](#a9) | 16 |
| &nbsp;&nbsp;&nbsp;[Item 1A. Risk Factors.](#a10) | 16 |
| &nbsp;&nbsp;&nbsp;[Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.](#a11) | 16 |
| &nbsp;&nbsp;&nbsp;[Item 3. Defaults Upon Senior Securities.](#a12) | 16 |
| &nbsp;&nbsp;&nbsp;[Item 4. Mine Safety Disclosure.](#a13) | 16 |
| &nbsp;&nbsp;&nbsp;[Item 5. Other Information.](#a14) | 16 |
| &nbsp;&nbsp;&nbsp;[Item 6. Exhibits.](#a15) | 17 |
| [SIGNATURES](#a16) | 18 |

---

------

iii

------

**PART I - FINANCIAL INFORMATION**

**Item 1. Financial statements.**

**ALPHEGA INNOVATIONS CORPORATION**

**Balance Sheets**

**As of February 28, 2026**

---

| | | |
|:---|:---|:---|
|  | **February 28,**<br> **2026** | **November 30,**<br> **2025** |
|  | (Unaudited) | (Audited) |
| **Assets** |  |  |
| &nbsp;&nbsp;&nbsp;**Current Assets** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash | $6721 | $2070 |
| &nbsp;&nbsp;&nbsp;**Total Current Assets** | 6721 | 2070 |
| **Total Assets** | 6721 | 2070 |
| **Liabilities and Stockholders' (Deficit)** |  |  |
| &nbsp;&nbsp;&nbsp;**Current Liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Short term business loan | 17000 | 17000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loan from related parties | 72000 | 32000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and Accrued liability | 403283 | 309927 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Due to related parties | 2768740 | 1881592 |
| &nbsp;&nbsp;&nbsp;**Total Current Liabilities** | 3261023 | 2240519 |
| &nbsp;&nbsp;&nbsp;**Total Liabilities** | 3261023 | 2240519 |
| &nbsp;&nbsp;&nbsp;**Stockholders' Deficit** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock $0.0001 par value; 500,000,000 shares authorized; 14,830,740 and 14,670,000 shares issued and outstanding as of February 28, 2026, and November 30, 2025, respectively | 1483 | 1467 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred stock $0.0001 par value; 200,000,000 shares authorized; nil shares issued | - | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional Paid-in Capital | 248357 | 87633 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (3504142) | (2327549) |
| &nbsp;&nbsp;&nbsp;**Total Stockholders' Deficit** | (3254302) | (2238449) |
| **Total Liabilities and Stockholders' (Deficit)** | $6721 | $2070 |

---

The accompanying notes are an integral part of these unaudited financial statements.

------

**ALPHEGA INNOVATIONS CORPORATION**

**Statements of Operations**

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **For the three months ended**<br> **February 28,** | **For the three months ended**<br> **February 28,** |
|  | **2026** | **2025** |
| **Expenses** |  |  |
| &nbsp;&nbsp;&nbsp;Consulting | $140250 | $64600 |
| &nbsp;&nbsp;&nbsp;Legal and professional services | 840729 | 548210 |
| &nbsp;&nbsp;&nbsp;Dues and subscriptions | 433 | - |
| &nbsp;&nbsp;&nbsp;Regulatory fee | 450 | - |
| &nbsp;&nbsp;&nbsp;Advertising & marketing | 23800 | - |
| &nbsp;&nbsp;&nbsp;Training | 23800 | - |
| &nbsp;&nbsp;&nbsp;Loss on settlement of service | 144666 | - |
| **Total Expenses** | 1174128 | 612810 |
| **Loss from Operations** | (1174128) | (612810) |
| **Other Income & expense** |  |  |
| &nbsp;&nbsp;&nbsp;Financial charges | 2449 | - |
| &nbsp;&nbsp;&nbsp;Other expense | 16 | 398 |
| **Net Loss before Income Tax** | (1176593) | (613208) |
| &nbsp;&nbsp;&nbsp;Income taxes | - | - |
| **Net Loss** | $(1176593) | $(613208) |
| **Basic and Diluted Weighted Average Shares Outstanding** | 14749666 | 14670000 |
| **Basic and Diluted Net Loss per Share** | $(0.08) | $(0.04) |

---

The accompanying notes are an integral part of these unaudited financial statements.

------

**ALPHEGA INNOVATIONS CORPORATION**

**Statements of Changes in Stockholders' Deficit**

(Unaudited)

*For the three months ended February 28, 2025*

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | **Preferred Stock** | **Preferred Stock** | **Preferred Stock** |  |  |  |  |
|  | **Shares** | **Amount** | **Amount** | **Shares** | **Amount** | **Subscription**<br> **Receivable** | **Additional**<br> **Paid-In-**<br> **Capital** | **Accumulated**<br> **Deficit** | **Total** |
| Balance as of November 30, 2024 | 14670000 | $1467 | 1467 | - | $- | $(59100) | $87633 | $(47945) | $(17945) |
| &nbsp;&nbsp;&nbsp;Proceeds from the sale of common stock | - | - | - | - | - | 59100 | - | - | 59100 |
| &nbsp;&nbsp;&nbsp;Net Loss | - | - | - | - | - | - | - | (613208) | (613208) |
| Balance as of February 28, 2025 | 14670000 | $1467 | 1467 | - | $- | $- | $87633 | $(661153) | $(572053) |

---

*For the three months ended February 28, 2026*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | **Preferred Stock** | **Preferred Stock** |  |  |  |  |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Subscription**<br> **Receivable** | **Additional**<br> **Paid-In-**<br> **Capital** | **Accumulated**<br> **Deficit** | **Total** |
| Balance as of November 30, 2025 | 14670000 | $1467 | - | $- | $- | $87633 | $(2327549) | $(2238449) |
| &nbsp;&nbsp;&nbsp;Issuance of common stock for services | 160740 | 16 | - | - | - | 160724 | - | 160740 |
| &nbsp;&nbsp;&nbsp;Net Loss | - | - | - | - | - | - | (1176593) | (1176593) |
| Balance as of February 28, 2026 | 14830740 | $1483 | - | $- | $- | $248357 | $(3504142) | $(3254302) |

---

The accompanying notes are an integral part of these unaudited financial statements.

------

**ALPHEGA INNOVATIONS CORPORATION**

**Statements Of Cash Flows**

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **For the three months ended**<br> **February 28,** | **For the three months ended**<br> **February 28,** |
|  | **2026** | **2025** |
| **Cash Flows from Operating Activities** |  |  |
| &nbsp;&nbsp;&nbsp;Net Loss | $(1176593) | $(613208) |
| Adjustments to reconcile net loss to net cash provided by operating activities |  |  |
| &nbsp;&nbsp;&nbsp;Common stock issued for services | 160740 | - |
| Net changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Due to Related Party | 887149 | 588311 |
| &nbsp;&nbsp;&nbsp;Accounts payable and Accrued liabilities | 93355 | 8499 |
| **Net Cash Used in Operating Activities** | (35349) | (16398) |
| **Net Cash Flow from Financing Activities** |  |  |
| &nbsp;&nbsp;&nbsp;Subscription receivable | - | 59100 |
| &nbsp;&nbsp;&nbsp;Loan from related party | 40000 | - |
| **Net Cash Provided by Financing Activities** | 40000 | 59100 |
| **CHANGE IN CASH** | 4651 | 42702 |
| CASH AT BEGINNING OF PERIOD | 2070 | - |
| **CASH AT END OF PERIOD** | $6721 | $42702 |
| **Supplemental Cash Flow Information:** |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid for interest  | $- | $- |
| &nbsp;&nbsp;&nbsp;Cash paid for income taxes | $- | $- |

---

The accompanying notes are an integral part of these unaudited financial statements.

------

**ALPHEGA INNOVATIONS CORPORATION**

**Notes to Financial Statements**

(Unaudited)

------

**NOTE 1 -** **DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS**

Alphega Innovations Corporation ("Alphega" or the "Company") was incorporated in Wyoming on July 24, 2024. We are a development-stage company focused on the immersive technology industry, aiming to meet the growing demand for personal and corporate solutions. These include corporate wellness, employee training, digital education, market research, and community engagement, all driven by innovation in corporate services, workforce development, and employee well-being. Our solutions will incorporate advanced technologies such as augmented reality (AR), virtual reality (VR), and Metaverse environments.

Our initial focus will be on the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Developing immersive Platforms and Applications: Creating AR/VR-enabled applications for corporate wellness, mental health solutions, and fitness transformation, with potential integration of Artificial Intelligence (Al) for enhanced personalization.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Establishing Strategic Partnerships: Collaborating with businesses, educational institutions, and wellness centers to pilot and refine our solutions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Launching Marketing Initiatives: Targeting key markets, including corporate HR departments fitness centers, and health organizations, to raise awareness and gather feedback.

**Going Concern Consideration**

The Company's unaudited financial statements as of February 28, 2026, have been prepared using generally accepted accounting principles in the United States of America ("GAAP") applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The Company has accumulated losses as of February 28, 2026, totaling $3,504,142. These factors, among other, raise substantial doubt about the ability of the company to continue as a going concern for a reasonable period. The company plans to raise capital through private placement or borrowing arrangements.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management's plan is to obtain such resources for the Company by obtaining capital from management and significant shareholders sufficient to meet its minimal operating expenses and seeking third-party equity and/or debt financing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

**NOTE 2 -** **SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

**Basis of Presentation**

The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the rules and regulations of the SEC.

**Use of Estimates**

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

------

**ALPHEGA INNOVATIONS CORPORATION**

**Notes to Financial Statements**

(Unaudited)

------

**Income Taxes**

The Company complies with the accounting and reporting requirements of ASC Topic 740, "Income Taxes," which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company's management determined that the United States is the Company's only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits as of February 28, 2026, and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position.

The Company may be subject to potential examination by United States taxing authorities in income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with United States tax laws. The Company's management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is incorporated in the United States and is subject to U.S. federal and applicable state income tax laws. The Company has no operations or taxable presence in any other jurisdiction. Due to operating losses incurred during the periods presented, the Company did not recognize any provision for income taxes and had no current income tax expense. Accordingly, the Company's tax provision was zero for the periods presented.

**Net Loss Per Share**

Net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the period in accordance with ASC 260, Earning per Share. On February 28, 2026, we had outstanding common shares of 14,830,740. Basic weighted average common shares and equivalents for the periods ended February 28, 2026, and 2025, are 14,749,666 and 14,670,000 respectively.

**Concentration of Credit Risk**

Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account, and management believes the Company is not exposed to significant risks on such account.

**Fair Value of Financial Instruments**

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants as of the measurement date. Applicable accounting guidance provides an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of our Company. Unobservable inputs are inputs that reflect our Company's assumptions about the factors that market participants would use in valuing the asset or liability. The fair value hierarchy consists of the following three levels of inputs that may be used to measure fair value:

Level 1 -Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2 -Inputs other than quoted prices included in Level 1 that are observable in the marketplace either directly (i.e., as prices) or indirectly (i.e., derived from prices).

Level 3 -Unobservable inputs which are supported by little or no market activity.

The fair value of the Company's liabilities, which qualify as financial instruments under ASC Topic 820, "Fair Value Measurements and Disclosures," approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

------

**ALPHEGA INNOVATIONS CORPORATION**

**Notes to Financial Statements**

(Unaudited)

------

**Stock-based Compensation**

The Company follows ASC 718-10, Stock Compensation, which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized. The Company has not adopted a stock option plan and has not granted any stock options.

**Recently Issued Accounting Standards**

Management does not believe that any recently issued but not yet effective accounting pronouncements, if adopted, would have a material effect on the Company's financial statements.

**NOTE 3 -** **SHAREHOLDERS DEFICIT**

**Common Stock**

Authorized: 500,000,000 shares of voting common stock with a par value of $0.0001, 200,000,000 shares of preferred stock with a par value of $0.0001. As of February 28, 2026, and 2025, the Company had 14,830,740 and 14,670,000 common stocks issued and outstanding, respectively. No preferred stocks were issued as of February 28, 2026, and 2025, respectively.

For the period between inception and February 28, 2026, the Company engaged in the following equity events:

Sale of Common Stock and Subscriptions

From July 24, 2024, through November 30, 2024, the Company issued 5,370,000 shares of the Company's common stock to investors for an aggregate purchase price of $59,100. The company booked these transactions as subscription receivable as of November 30, 2024. The company received the proceeds from investors in January 2025.

Shares issued for license fees

From July 24, 2024, through November 30, 2024, the Company issued 300,000 shares of the Company's common stock to Locus Social Inc. as initial license fee of $30,000.

Shares issued to founders

On July 29, 2024, the Company issued 9,000,000 shares of the Company's Common Stock to founders.

Shares issued for services

On December 31, 2025, the Company issued 118,800 shares of common stock to Soho Capital Solutions in exchange for services rendered. Although the agreed price was $0.10 per share (totaling $11,880), the shares were recorded at their estimated fair value of $1.00 per share, resulting in a total recognized value of $118,800. Accordingly, the Company recognized a loss on settlement of services of $106,920, representing the excess of the fair value of the shares issued over the agreed consideration.

On February 28, 2026, the Company issued 41,940 shares of common stock to Soho Capital Solutions in exchange for services rendered. Although the agreed price was $0.10 per share (totaling $4,194), the shares were recorded at their estimated fair value of $1.00 per share, resulting in a total recognized value of $41,940. Accordingly, the Company recognized a loss on settlement of services of $37,746, representing the excess of the fair value of the shares issued over the agreed consideration.

------

**ALPHEGA INNOVATIONS CORPORATION**

**Notes to Financial Statements**

(Unaudited)

------

**NOTE 4 -** **CURRENT LOAN TRANSACTIONS**

The Company entered into a loan agreement with Sun Yun Bo on April 10, 2025. The total amount of money being borrowed from the Lender (SUN YUN BO) is $1,000.

The total amount of the Borrowed Money, including principal and interest, shall be due and payable in 18 months ("Due Date"), and the Loan can be renewed after eighteen (18) months at a rate equal to the Interest Rate above SOFR (meaning SOFR plus Interest Rate (12%), also referred to as Renewed Interest Rate). The total principal plus accrued interest from Sun Yun Bo as of February 28, 2026, is $1,106.

The Company entered into a loan agreement with Chen Qi on August 18, 2025. The total amount of money borrowed from the lender (Chen Qi) is $5,000.

The total amount of the Borrowed Money, including principal and interest, shall be due and payable in 12 months ("Due Date"), and the Loan can be renewed after twelve (12) months at a rate equal to the Interest Rate above SOFR (meaning SOFR plus Interest Rate (8%), also referred to as Renewed Interest Rate). The net proceeds of $4,854.10, after deduction of processing fees, were received on August 21, 2025. The total principal plus accrued interest from Chen Qi as of February 28, 2026, is $5,211.

The Company entered into a loan agreement with Chen Tingting on August 18, 2025. The total amount of money borrowed from Chen Tingting is $3,000.

The total amount of the Borrowed Money, including principal and interest, shall be due and payable in 12 months ("Due Date"), and the Loan can be renewed after twelve (12) months at a rate equal to the Interest Rate above SOFR (meaning SOFR plus Interest Rate (8%), also referred to as Renewed Interest Rate). The net proceeds of $2,912.70, after deduction of processing fees, were received on August 25, 2025. The total principal plus accrued interest from Chen Tingting as of February 28, 2026, is $3,124.

The Company entered into a loan agreement with CUI Xiangdong on September 1, 2025. The total amount of money borrowed from Chen Tingting is $1,000.

The loan bears interest at 8% per annum and will be due in full, including accrued interest, on September 1, 2026 (the "Due Date"). The loan may be renewed at maturity for an additional 12-month term at a rate equal to SOFR plus 8% (the "Renewed Interest Rate"). The total principal plus accrued interest from CUI Xiangdong as of February 28, 2026, is $1,039.

On September 15, 2025, the Company entered into separate loan agreements with six individual lenders:

Xue Yiming, Guo Xue, Huang Zhigang, Huang Shanli, He Yan, and Luo Wenhao (collectively, the "Lenders"), for a total principal amount of $7,000. Each lender will enter into a distinct agreement with the Company. Under the terms of the agreements, each lender will contribute $1,000, except for Huang Zhigang, who will lend $2,000. The loans will bear interest at a fixed rate of 8% per annum and will mature on 12-months period (the "Due Date"), at which time the full principal amount, together with all accrued interest, shall become due and payable. Upon maturity, the loans may be renewed for an additional 12-month term at an interest rate equal to the Secured Overnight Financing Rate (SOFR) plus 8% per annum (the "Renewed Interest Rate"). The total principal plus accrued interest from each party as of February 28, 2026, is $7,250.

------

**ALPHEGA INNOVATIONS CORPORATION**

**Notes to Financial Statements**

(Unaudited)

------

**NOTE 5 -** **RELATED PARTY TRANSACTIONS**

The related parties had transactions for the THREE months ended February 28, 2026, consisting of the following:

---

| | |
|:---|:---|
| **Name of the related parties** | **Nature of relationship** |
| Lingyun Mao | Shareholder |
| Fairbanks Global Partners II LLC | Shareholder |
| One World Engineering Corporation | Shareholder |
| Want Pty Ltd ATF Wang Family Trust | Shareholder |
| Shabnoor Shah | Shareholder |
| Luis Carlos Ung | Shareholder, President, CEO, CFO |
| Taurus Era Corporation | Entity under the common control |
| Alphega Global Partners Corporation | Entity under the common control |
| IM Abundance Pty Ltd | Entity under the common control |

---

\* Hung Fong Wang Key Management Personnel of IM Abundance and Alphega Innovation Corporation (AIC) resigned from AIC on October 1, 2025, while this entity is still a related party due to Hung Fong Wang, who is still shareholder of AIC.

---

| | | |
|:---|:---|:---|
|  | **As of**<br> **February 28, 2026** | **As of**<br> **November 30, 2025** |
| **Accrued Services** |  |  |
| Lingyun Mao | $315 | $315 |
| Fairbanks Global Partners II LLC | 1286474 | 902525 |
| One World Engineering Corporation | 945189 | 582239 |
| Wang Pty Ltd ATF Wang Family Trust | 250 | 250 |
| Shabnoor Shah | 448325 | 308075 |
| IM Abundance Pty Ltd | 88188 | 88188 |
| **Total Due to related party** | $2768740 | $1881592 |

---

As of February 28, 2026, balances due to related parties primarily represent the consulting and professional services provided by the shareholders.

The Company entered into the loan agreement with Luis Carlos Ung on May 20, 2025. The total amount of money being borrowed from Luis Carlos Ung was $12,000.

The total amount of the Borrowed Money, including principal and interest, shall be due and payable in 18 months ("Due Date"), and the Loan can be renewed after eighteen (18) months at a rate equal to the Interest Rate above SOFR (meaning SOFR plus Interest Rate (12%), also referred to as Renewed Interest Rate). The total principal plus accrued interest from Luis Carlos as of February 28, 2026, is $13,124.

On October 2, 2025, Alphega Innovations Corporation entered into a loan agreement with One World Engineering Corporation for principal financing of $20,000.

The loan bears interest at a fixed rate of 12% per annum and matures 12 months from the effective date. The loan is secured by a first-priority security interest in substantially all assets of the Company and is classified as senior secured debt. At the lender's sole discretion, the outstanding principal and accrued interest may be converted into common shares of the Company at $0.03 per share. Interest is accrued monthly and payable at maturity unless earlier converted or repaid. The total principal plus accrued interest from One World Engineering Corporation as of February 28, 2026, is $21,000.

On December 8, 2025, the Company entered into a loan agreement with Taurus Era Corporation for $15,000. The loan bears interest at 12% per annum and matures 12 months from the effective date. The loan is secured by a first-priority security interest over all Company assets and ranks as senior secured debt. The total principal plus accrued interest from Taurus Era Corporation as of February 28, 2026, is $15,415.

------

**ALPHEGA INNOVATIONS CORPORATION**

**Notes to Financial Statements**

(Unaudited)

------

On January 27, 2026, Alphega Innovations Corporation entered into a loan agreement with Alphega Global Partners Corporation for principal financing of $25,000.

The loan bears interest at a fixed rate of 12% per annum and matures 12 months from the effective date. The loan is secured by a first-priority security interest in substantially all assets of the Company and is classified as senior secured debt. Interest is accrued monthly and payable at maturity unless earlier repaid. The total principal plus accrued interest from Alphega Global Partners Corporation as of February 28, 2026, is $25,283.

**NOTE 6 -** **SUBSEQUENT EVENTS**

In accordance with ASC Topic 855, "Subsequent Events", which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date and through the date of this filing. The Company has reviewed subsequent events occurring after the balance sheet date and has determined that these events necessitate adjustments to or disclosure in the accompanying financial statements.

On March 10, 2026, the Company entered into a loan agreement with Alphega Global Partners Corporation for $9,000. The loan bears interest at 12% per annum and matures 12 months from the effective date. The loan is secured by a first-priority security interest over all Company assets and ranks as senior secured debt.

On March 24, 2026, the Company entered into a share subscription agreement with JE Omnitrade, Inc. for a total consideration of $300,000 for the issuance of 300,000 ordinary shares at $1.00 per share. Under the terms of the agreement, an initial payment of $100,000 is payable upon execution, with the remaining balance of $200,000 to be settled in monthly installments of $50,000. Accordingly, 100,000 shares are issued on March 30, 2026, against the initial $100,000 investment. The remaining shares will be issued on a pro rata basis corresponding to installments received. In the event of non-payment of any installment, the Company reserves the right to suspend further share issuances and/or terminate the agreement with respect to the unpaid portion.

------

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

**CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS**

This Quarterly Report on Form 10-Q includes "forward-looking statements". These statements relate to future events or our future financial performance. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "should" or "will" or the negative of these terms or other comparable terminology.

These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under "Risk Factors." The following factors, among others, could cause our actual results and performance to differ materially from the results and performance projected in, or implied by, the forward-looking statements:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·the success of our existing and new technologies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·our ability to successfully develop and expand our operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·changes in economic conditions, including continuing effects from the recent recession;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·damage to our reputation or lack of acceptance of our brands;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·economic and other trends and developments, including adverse weather conditions, in those local or regional areas in which our operations are concentrated;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·increases in our labor costs, including as a result of changes in government regulation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·labor shortages or increased labor costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·increasing competition in the industry in general;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·changes in attitudes or negative publicity regarding drug safety and health concerns;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·the success of our marketing programs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·potential fluctuations in our quarterly operating results due to new products and other factors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·the effect on existing products of focusing on other products in the same markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·our management team;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·strain on our infrastructure and resources caused by our growth;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·the impact of federal, state, or local government regulations relating to the industry;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·the impact of litigation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·statements regarding our goals, intentions, plans, and expectations, including the introduction of new products and markets and locations we intend to target in the future;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·statements regarding the anticipated timing and impact of our pending acquisitions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·statement regarding our expectation with respect to the potential issuance of stock or shares in connection with our acquisitions or in connection with providing services to client companies.; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·statement with respect to having adequate liquidity.

The following factors, among others, could cause actual results to differ materially from the anticipated results or other expectations expressed in the forward-looking statements:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·changes in the pace of legislation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·other regulatory developments that could limit the market for our products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·our ability to successfully integrate acquired entities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·competitive developments, including the possibility of new entrants into our primary markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·the loss of key personnel; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·other risks discussed in this document.

Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this Quarterly Report on Form 10-Q are reasonable, we can give no assurance that these plans, intentions or expectations will be achieved or occur, and actual results could differ materially and adversely from those anticipated or implied by the forward-looking statements.

All forward-looking statements, expressed or implied, included in this Quarterly Report on Form 10-Q are expressly qualified in their entirety by this cautionary statement. This cautionary statement should also be considered in connection with any subsequent written or oral forward-looking statements that we or persons acting on our behalf may issue.

------

Except as otherwise required by applicable law, we disclaim any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q.

**General**

**Overview**

Alphega Innovations Corporation (the "Company") was incorporated in Wyoming on July 24, 2024. The Company is an emerging growth company focused on the immersive technology industry, aiming to meet the growing demand for personal and corporate solutions. These include corporate wellness, employee training, digital education, market research, and community engagement, all driven by innovation in corporate services, workforce development, and employee well-being.

**Our corporate History and Background**

The Company was incorporated in Wyoming on July 24, 2024. To date, we have incorporated the Company, developed a business plan, raised $59,100 through a private placement of common stock to officers, directors, and private investors, and entered into a significant licensing agreement. On November 30, 2024, we signed a Non-Exclusive Licensing Agreement with Locus Social Inc. This agreement provides us with access to patented technologies critical to our immersive wellness solutions. The agreement is valid for 10 years and is renewable for additional terms unless terminated for breach or non-payment.

**Business Overview**

Our initial focus will be on the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Developing immersive Platforms and Applications: Creating AR/VR-enabled applications for corporate wellness, mental wellness solutions, and fitness transformation, with potential integration of Artificial Intelligence (Al) for enhanced personalization.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Establishing Strategic Partnerships: Collaborating with businesses, educational institutions, and wellness centers to pilot and refine our solutions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Launching Marketing Initiatives: Targeting key markets, including corporate HR departments, fitness centers, and health organizations, to raise awareness and gather feedback.

Our immediate goal is to explore the use and commercialization of our licensed technologies for immersive wellness and corporate development solutions by identifying use cases, developing proof of concept, and positioning for scaling and revenue generation, and execution of our business plan. Efforts include building a team, creating a minimum viable product and service offering, and preparing marketing materials, subject to sufficient funding and market demand. Given the complexity of our technology, the market, and our lack of operating history, as well as uncertainty regarding funding and the availability of resources, including cash, and many other risk factors (See "Risk Factors") there can be no assurance that these efforts will be successful. Success is dependent on factors outside of our control, including market conditions, customer demand, the ability to secure adequate funding, and the development and acceptance of our products and solutions, and many other factors.

As a development-stage company with limited operating history, we estimate that at least $250,000 will be required over the next twelve months to execute the next phase of operations, as outlined in our "Plan of Operations." If we are unable to secure sufficient funding or generate revenue within this timeframe, our ability to continue operations and achieve our objectives may be at significant risk. There can be no assurance that we will be able to obtain the necessary funding or successfully execute our business plan.

------

**Results of Operations and Financial Condition**

***Three Months Ended February 28, 2026, Compared to the Period Ended February 28, 2025***

Since the Company's inception on July 24, 2024, the Company has focused on building its operational foundation, conducting strategic planning, pursuing business development, pursuing funding, and entering into a licensing agreement. Operating activities included company formation, business planning, leadership recruitment, and the execution of the licensing agreement.

From December 1, 2024, through February 28, 2025, the Company incurred total operating expenses of $613,208, which were primarily related to consulting services necessary for initial corporate setup and strategic planning.

For the three months ended February 28, 2026, the Company incurred net losses of $1,176,593. These losses were entirely attributable to operating expenses, as the Company has not yet commenced principal operations and has not generated any operating revenues to date.

**Liquidity and Capital Resources**

As of November 30, 2025, the Company had cash and cash equivalents of $2,070.

As of February 28, 2026, the Company had cash and cash equivalents of $6,721.

We have sustained net losses which have resulted in an accumulated deficit at February 28, 2026, of $3,504,142, and are currently experiencing a substantial shortfall in operating capital which raises doubt about our ability to continue as a going concern. Without additional revenues, working capital loans, or equity investment, there is substantial doubt as to our ability to commence and continue operations.

However, subsequent to the period end, the Company entered into a share subscription agreement with JE Omnitrade, Inc. for total consideration of $300,000 for the issuance of 300,000 common shares at $1.00 per share. Under the terms of the agreement, an initial payment of $100,000 was received on March 30, 2026, with the remaining balance of $200,000 to be settled in monthly installments of $50,000. Shares will be issued on a pro rata basis corresponding to installments received. Management believes that the funds received to date, together with the expected future installments under this agreement, will partially alleviate the Company's operating capital shortfall and improve its liquidity position. Accordingly, while uncertainties remain, these developments reduce the level of doubt regarding the Company's ability to continue as a going concern.

We believe that our capital resources are insufficient for ongoing operations, with minimal current cash reserves, particularly given the resources necessary to execute on our planned operations. We will likely require considerable amounts of financing to make any significant advancement in our business strategy. There is presently no agreement in place that will guarantee financing for our Company, and we cannot assure you that we will be able to raise any additional funds, or that such funds will be available on acceptable terms. Funds raised through future equity financing will likely be substantially dilutive to current shareholders. Lack of additional funds will materially affect our Company and our business and may cause us to substantially curtail or even cease operations. Consequently, you could incur a loss of your entire investment in the Company.

**Cash Flows from Operating, Investing and Financing Activities**

The following table summarizes our cash flows for the period indicated:

---

| | | |
|:---|:---|:---|
|  | **For the three months ended**<br> **February 28,** | **For the three months ended**<br> **February 28,** |
|  | **2026** | **2025** |
| Cash flows from operating activities | $(35349) | $(16398) |
| Cashflow from investing activities | $- | $- |
| Cashflow from financing activities | $40000 | $59100 |

---

------

**Operating Activities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Net cash used in operating activities amounted to $(35,349) for the three months ended February 28, 2026, compared to $(16,398) for the three months ended February 28, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·The increase in net cash used in operating activities was primarily attributable to higher working capital requirements and increased operating expenses during the period.

**Investing Activities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·No cash flows from investing activities were reported in either period, indicating no acquisition or disposal of long-term assets during the quarters under review.

**Financing Activities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Net cash provided by financing activities amounted to $40,000 for the three months ended February 28, 2026, compared to $59,100 for the year ended February 28, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·The decrease in cash provided by financing activities was primarily attributable to the absence of proceeds from share subscriptions during the three months ended February 28, 2026, compared to the prior-year period, which included proceeds from share subscriptions. Cash provided by financing activities in the current period relates to proceeds from debt financing.

**Off-Balance Sheet Arrangements**

As of February 28, 2026, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to investors.

**Critical Accounting Policies**

We have identified the policies in the attached financial statements as critical to our business operations and an understanding of our results of operations. The list is not intended to be a comprehensive list of all of our accounting policies. In many cases, the accounting treatment of a particular transaction is specifically dictated by accounting principles generally accepted in the United States, with no need for management's judgment in their application. The impact and any associated risks related to these policies on our business operations are discussed throughout Management's Discussion and Analysis of Financial Condition and Results of Operation where such policies affect our reported and expected financial results. Note that our preparation of the financial statements requires us to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities at the date of our financial statements, and the reported amounts of revenue and expenses during the reporting period. There can be no assurance that actual results will not differ from those estimates. For more information, see "Note 2 - Summary of Significant Accounting Policies" in the attached financial statements.

**Recently Issued Accounting Pronouncements**

The information contained in Note 2 - Summary of Significant Accounting Policies to the statements under the heading "Recently Issued Accounting Pronouncements" is hereby incorporated by reference into Part I, Item 2. From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board ("FASB") or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption."

**Item 3. Quantitative and Qualitative Disclosures about Market Risk.**

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

------

**Item 4. Controls and Procedures.**

***Evaluation of Disclosure Controls and Procedures***

Luis Carlos Ung, our Chief Executive Officer and Interim Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our Chief Executive Officer and Interim Chief Financial Officer concluded that, as of February 28, 2026, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Interim Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

***Changes in Internal Control Over Financial Reporting***

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended February 28, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

**PART II - OTHER INFORMATION**

**Item 1. Legal Proceedings.**

We are not currently a party to any material legal proceedings, and we are not aware of any material legal proceedings pending or threatened against us.

**Item 1A. Risk Factors.**

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.**

During the quarter ended February 28, 2026, the Company issued the following unregistered securities pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506 of Regulation D thereunder. No underwriters were involved and no commissions were paid.

(a) On December 31, 2025, the Company issued 118,800 shares of its common stock to Soho Capital Solutions in exchange for services rendered. Although the agreed price was $0.10 per share (totaling $11,880), the shares were recorded at their estimated fair value of $1.00 per share, resulting in a total recognized value of $118,800. Accordingly, the Company recognized a loss on settlement of services of $106,920 in the Statement of Operations for the three months ended February 28, 2026.

(b) On February 28, 2026, the Company issued 41,940 shares of its common stock to Soho Capital Solutions in exchange for services rendered. Although the agreed price was $0.10 per share (totaling $4,194), the shares were recorded at their estimated fair value of $1.00 per share, resulting in a total recognized value of $41,940. Accordingly, the Company recognized a loss on settlement of services of $37,746 in the Statement of Operations for the three months ended February 28, 2026.

The aggregate fair value of the shares issued for services during the quarter was $160,740, which is reflected in the financial statements as stock-based compensation expense (with the excess over the agreed service price recorded as a loss on settlement of services). No cash proceeds were received from these issuances.

**Item 3. Defaults Upon Senior Securities.**

None.

**Item 4. Mine Safety Disclosure.**

Not applicable.

**Item 5. Other Information.**

During the three months ended February 28, 2026, none of our directors or officers (as defined in Rule 16a-1 under the Securities Exchange Act of 1934, as amended (the "Exchange Act")), adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any "non-Rule 10b5-1 trading arrangement" (as defined by Item 408(c) of Regulation S-K). However, certain of our directors and officers may adopt 10b5-1 plans or non-Rule 10b5-1 trading arrangements in the future.

------

**Item 6. Exhibits.**

The following exhibits are included as part of this report:

---

| | | | |
|:---|:---|:---|:---|
|  |  | **Incorporated by**<br> **Reference** | **Incorporated by**<br> **Reference** |
| **Exhibit**<br> **No.** | **Description** | **Filing**<br> **Type** | **Date**<br> **Filed** |
| [3.1](http://www.sec.gov/Archives/edgar/data/2038564/000113902025000058/alpga_ex31.htm) | Articles of Incorporation | S-1 | 04/14/2025 |
| [3.2](http://www.sec.gov/Archives/edgar/data/2038564/000113902025000058/alpga_ex32.htm) | Bylaws | S-1 | 04/14/2025 |
| [10.1](http://www.sec.gov/Archives/edgar/data/2038564/000113902025000058/alpga_ex101.htm) | License Agreement dated November 30, 2024, with Locus Social, Inc. | S-1 | 04/14/2025 |
| [31.1](alpga_ex311.htm) | Certification of Chief Executive Officer and Interim Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.<br> \* |  |  |
| [32.1](alpga_ex321.htm) | Certification of Chief Executive Officer and Interim Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002<br> \* |  |  |
| 101.INS | Inline XBRL Instance Document |  |  |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |  |  |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  |  |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |  |  |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |  |  |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  |  |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |  |  |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: | April 13, 2026 | By: */s/ Luis Carlos Ung* |
|  |  | Name: Luis Carlos Ung<br> Title: Chief Executive Officer and Interim Chief Financial Officer |

---

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| */s/ Luis Carlos Ung*<br> Name: Luis Carlos Ung | President, CEO, Interim Chief Financial Officer, Secretary, Director<br> (Principal Executive, Financial and Accounting Officer) | April 13, 2026 |

---

------

## Exhibit 31.1

**CELL MEDX CORP.**

**CERTIFICATIONS PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Luis Carlos Ung, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the period ending February 28, 2026, of Alphega Innovations Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an Annual Report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: April 13, 2026

*/s/ Luis Carlos Ung*

Luis Carlos Ung

Chief Executive Officer and Interim Chief Financial Officer

(Principal Executive, Financial and Accounting Officer)

## Exhibit 32.1

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Alphega Innovations Corp. (the "Company") on Form 10-Q for the period ending February 28, 2026, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: April 13, 2026

*/s/ Luis Carlos Ung*

Luis Carlos Ung

Chief Executive Officer and Interim Chief Financial Officer

(Principal Executive, Financial and Accounting Officer)